The deals are still pouring in, and IPO investors are poring over them. Nine IPOs raised a hefty $3.3 billion this past week. Excluding a SPAC and a Reg A+, the average return was just 2%. The week's sole energy offering, FTS International, was...read more
Sol-Gel Technologies, which is developing topical acne creams that deliver treatment via microcapsules, raised $75 million by offering 6.25 million shares at $12, the midpoint of the $11 to $13 range. It had previously planned to offer 5 million shares at the...read more
The IPO market continues its record-breaking start of the year with nine deals aiming to raise $3.5 billion. Casino REIT Vici Properties headlines the week with a $1 billion IPO. And the big deals keep coming: Three more target over $500 million, including...read more
Sol-Gel Technologies, which is developing topical acne creams that deliver treatment via microcapsules, announced terms for its IPO on Tuesday. The Ness Ziona, Israel-based company plans to raise $60 million by offering 5 million shares at a price range of...read more
US IPO Weekly Recap: Heavy volume but few winners in 9-IPO week
The deals are still pouring in, and IPO investors are poring over them. Nine IPOs raised a hefty $3.3 billion this past week. Excluding a SPAC and a Reg A+, the average return was just 2%. The week's sole energy offering, FTS International, was...read more
Acne biotech Sol-Gel Technologies prices upsized IPO at $12 midpoint
Sol-Gel Technologies, which is developing topical acne creams that deliver treatment via microcapsules, raised $75 million by offering 6.25 million shares at $12, the midpoint of the $11 to $13 range. It had previously planned to offer 5 million shares at the...read more
US IPO Week Ahead: Another wave hits with 9 deals including the Caesars Palace REIT
The IPO market continues its record-breaking start of the year with nine deals aiming to raise $3.5 billion. Casino REIT Vici Properties headlines the week with a $1 billion IPO. And the big deals keep coming: Three more target over $500 million, including...read more
Sol-Gel Technologies, an Israeli acne biotech, sets terms for $60 million IPO
Sol-Gel Technologies, which is developing topical acne creams that deliver treatment via microcapsules, announced terms for its IPO on Tuesday. The Ness Ziona, Israel-based company plans to raise $60 million by offering 5 million shares at a price range of...read more